                         SEQUENCE LISTING

<110>  AEBI Ltd.
 
<120>  THERAPEUTIC MULTI-TARGETING CONSTRUCTS AND USES THEREOF

<130>  AEBI/002 PCT

<150>  62/401192
<151>  2016-09-29

<150>  62/401195
<151>  2016-09-29

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  1

Cys His Pro Gly Asp Lys Gln Glu Asp Pro Asn Cys Leu Gln Ala Asp 
1               5                   10                  15      


Lys 
    


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  2

Cys Glu Gly Leu Pro Ala Asp Trp Ala Ala Ala Cys 
1               5                   10          


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  3

Cys Ser Ala Arg Trp Gly Pro Thr Met Pro Trp Cys 
1               5                   10          


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  4

Cys Arg Arg Gly Ser Arg Ala Ser Gly Ala His Cys 
1               5                   10          


<210>  5
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  5

Met Arg Pro Glu Ile Trp Ile Ala Gln Glu Leu Arg Arg Ile Gly Asp 
1               5                   10                  15      


Glu Phe Asn Ala 
            20  


